Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.1450
0.00 (0.00%)
Jul 31, 2026, 2:49 PM HKT

HKG:8189 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-90.82-27.8-20.16-27.45-42.26
Depreciation & Amortization
9.499.1311.6315.059.51
Other Amortization
62.8--0.34-
Loss (Gain) From Sale of Assets
8.250.280.20.05-0.15
Asset Writedown & Restructuring Costs
27.377.16--22.26
Loss (Gain) From Sale of Investments
--0.94-5.96-2.34
Loss (Gain) on Equity Investments
-----1
Provision & Write-off of Bad Debts
1.929.999.484.8911.74
Other Operating Activities
-3.31-9.35-5.744.440.88
Change in Accounts Receivable
-5.71-12.0313.31-2.070.07
Change in Inventory
9.7411.9-16.551.2216.42
Change in Accounts Payable
13.37-7.18-5.41-8.81-14.24
Change in Unearned Revenue
-4.76-0.9915.215.85-11.26
Change in Other Net Operating Assets
-82.92-9.23-10.472.083.67
Operating Cash Flow
-54.58-26.27-13.15-12.82-6.68
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-8.26-2.56-2.47-8.8-27.6
Sale of Property, Plant & Equipment
1.772.940-0.71
Cash Acquisitions
-2.21---10.45-
Divestitures
-0.01-0.06-4.07-
Investment in Securities
--1.751.4924.05
Other Investing Activities
40.07-37.570.250.76-5.67
Investing Cash Flow
31.36-37.24-0.47-12.93-8.51

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--5.160.1-
Long-Term Debt Issued
83.2514790.9956.1247.6
Total Debt Issued
83.2514796.1556.2247.6
Short-Term Debt Repaid
---0.1--
Long-Term Debt Repaid
-137.12-64.05-83.32-50.05-19.5
Total Debt Repaid
-137.12-64.05-83.42-50.05-19.5
Net Debt Issued (Repaid)
-53.8782.9512.736.1728.1
Issuance of Common Stock
80.9----
Financing Cash Flow
27.0382.9512.736.1728.1

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
3.8119.44-0.89-19.5812.91

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-62.84-28.83-15.62-21.62-34.28
Free Cash Flow Growth
-----
Free Cash Flow Margin
-12.02%-7.48%-3.92%-5.36%-7.20%
Free Cash Flow Per Share
-0.03-0.01-0.01-0.01-0.02
Levered Free Cash Flow
77.61-48.97-4.2-13.24-25.89
Unlevered Free Cash Flow
79.98-46.1-0.97-9.24-22.48

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
3.794.586.086.45.47
Cash Income Tax Paid
0.160-0.04-1.49-0.06
Change in Working Capital
-70.29-17.53-3.91-1.73-5.33